Eikon Engineering Talent Community
TLDR
A program connecting engineers with upcoming opportunities across software, hardware, data, and platform engineering within a biopharma context.
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets.
Join our Engineering Talent Community
Do you thrive on solving complex problems, building innovative technologies, and enabling science through engineering - but don’t see the right role posted today? We’d love to stay connected.
By joining our Engineering Talent Community, you’ll have the opportunity to:
- Share your expertise and technical interests with our Talent Acquisition team.
- Be considered for upcoming opportunities across software, hardware, data, and platform engineering.
- Stay connected and informed about our Eikon’s growth and progress.
If you’re excited about applying engineering to transform biopharma and accelerate innovation, join our community so we can connect as the right opportunity becomes available.
Eikon is proud to be an equal opportunity employer and will consider all qualified applicants for employment.
We are currently not accepting any new third-party agencies or firms at this time. Please do not forward unsolicited agency resumes to our website, employees or Human Resources. Eikon Therapeutics will not pay fees to any third-party agency or firm associated with unsolicited resumes.
Eikon Therapeutics is a biopharmaceutical company focused on discovering innovative treatments for life-threatening diseases through a unique discovery platform. By leveraging advanced microscopy technology developed from Nobel Prize-winning research, Eikon enables real-time, molecular-resolution measurements of protein movement in living cells, allowing them to target previously inaccessible classes of proteins for drug development.